karuna therapeutics news

Karuna Therapeutics (NASDAQ:KRTX) COO Andrew Craig Miller sold 5,000 shares of the company’s stock in a transaction that occurred on Thursday, December 10th. Karuna Therapeutics Reports Third Quarter 2020 Financial Results and Provides General Business Update On track to initiate first Phase 3 trial within the EMERGENT program by the end of 2020 Topline data from Phase 1b trial in healthy elderly volunteers expected early in the second quarter of 2021 $344.9 million in cash, cash equivalents and investment securities expected to fund multiple Karuna Therapeutics News und KRTX Kursdiagramme. //-->